We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+13.9%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$312M
AUM Growth
+$49M
Cap. Flow
+$24.2M
Cap. Flow %
7.75%
Top 10 Hldgs %
48.72%
Holding
62
New
16
Increased
14
Reduced
12
Closed
19

Top Buys

Rank Stock Value
1
PCRX icon
Pacira BioSciences
PCRX
+$10.5M
2
PAY
Verifone Systems Inc
PAY
+$10.2M
3
HAIN icon
Hain Celestial
HAIN
+$8.59M
4
PDLI
PDL BioPharma, Inc.
PDLI
+$8.35M
5
ACOR
Acorda Therapeutics
ACOR
+$7.86M

Top Sells

Rank Stock Value
1
SGI
Somnigroup International
SGI
+$7.97M
2
TLRD
Tailored Brands, Inc.
TLRD
+$6.9M
3
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$6.59M
4
BDSI
BioDelivery Sciences International, Inc.
BDSI
+$6.26M
5
SNY icon
Sanofi
SNY
+$5.78M

Sector Composition

Rank Sector Weight
1 Healthcare 40.45%
2 Consumer Discretionary 17.85%
3 Consumer Staples 13.73%
4 Technology 2.85%
5 Communication Services 1.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABUS icon
26
Arbutus Biopharma
ABUS
$871M
$4.82M 1.55%
1,400,000
+992,000
+243% +$3.88M
FLO icon
27
Flowers Foods
FLO
$1.62B
$4.78M 1.53%
+316,000
New +$5.24M
AAP icon
28
Advance Auto Parts
AAP
$3.48B
$4.47M 1.44%
+30,000
New +$4.79M
TGT icon
29
Target
TGT
$63.7B
$4.4M 1.41%
+64,000
New +$4.59M
TTWO icon
30
Take-Two Interactive
TTWO
$45.3B
$4.15M 1.33%
92,000
-28,000
-23% -$1.18M
AEGR
31
DELISTED
Aegerion Pharmaceuticals
AEGR
$3.84M 1.23%
1,292,000
+492,000
+62% +$853K
FIT
32
DELISTED
Fitbit, Inc. Class A common stock
FIT
$3.71M 1.19%
+250,000
New +$3.65M
ALIM
33
DELISTED
Alimera Sciences
ALIM
$3.68M 1.18%
+164,800
New +$3.79M
SCTL
34
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$3.54M 1.13%
+446,000
New +$3.58M
TLRD
35
DELISTED
Tailored Brands, Inc.
TLRD
$3.36M 1.08%
214,000
-474,000
-69% -$6.9M
TTPH
36
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$2.54M 0.82%
33,200
+9,096
+38% +$729K
TENX icon
37
Tenax Therapeutics
TENX
$429M
$2.47M 0.79%
33
-2
-6% -$158K
BGFV
38
DELISTED
Big 5 Sporting Goods
BGFV
$2.42M 0.78%
+178,000
New +$2.18M
QLTI
39
DELISTED
QLT Inc
QLTI
$2.3M 0.74%
1,115,455
+20,000
+2% +$29.9K
MDGL icon
40
Madrigal Pharmaceuticals
MDGL
$12.7B
$1.67M 0.54%
132,000
+114,857
+670% +$1.11M
OCGN icon
41
Ocugen
OCGN
$427M
$852K 0.27%
+4,423
New +$692K
ZSAN
42
DELISTED
Zosano Pharma Corporation
ZSAN
$662K 0.21%
+1,197
New +$954K
BBWI icon
43
Bath & Body Works
BBWI
$4.13B
– –
-61,850
Closed -$3.36M
BLUE
44
DELISTED
bluebird bio
BLUE
– –
-7,411
Closed -$4.16M
HAIN icon
45
CALL
Hain Celestial
HAIN
$46M
– –
-150,000
Closed -$7.46M
LPCN icon
46
Lipocine
LPCN
$17.6M
– –
-23,529
Closed -$1.22M
ODP
47
CALL
DELISTED
ODP
ODP
– –
-13,990
Closed -$463K
PZZA icon
48
Papa John's
PZZA
$997M
– –
-58,000
Closed -$3.94M
RH icon
49
RH
RH
$3.4B
– –
-128,000
Closed -$3.67M
RRR icon
50
Red Rock Resorts
RRR
$3.8B
– –
-158,000
Closed -$3.47M
1
2
3

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DWM
Diversify Wealth Management Sandy, Utah $5.61B AUM 19.63% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
AIM
Alphinity Investment Management Sydney, Australia $5.68B AUM 26.72% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return

Armistice Capital's Q3 2016 Portfolio in Review

As of Q3 2016, Armistice Capital held 62 positions worth $312M, up 19% from $263M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Armistice Capital deployed $24.2M of net new capital in Q3 2016, opening 16 new positions and adding to 14 existing holdings. Its largest new stake was Pacira BioSciences: 268,000 shares worth $9.17M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 38% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was Tailored Brands, Inc., an estimated $6.9M trimmed.

  • Armistice Capital's largest Q3 2016 buy was Pacira BioSciences: 268,000 shares worth $9.17M.
  • Armistice Capital added most to Hain Celestial in Q3 2016, an estimated $8.59M increase.
  • Armistice Capital's biggest Q3 2016 reduction was Tailored Brands, Inc., cutting an estimated $6.9M.
  • Armistice Capital fully exited Somnigroup International in Q3 2016, selling an estimated $7.97M.
  • Armistice Capital's ten largest holdings make up 49% of its $312M portfolio in Q3 2016.
  • Armistice Capital opened 16 new positions and closed 19 in Q3 2016.
  • Armistice Capital's portfolio value rose 19% quarter-over-quarter to $312M.

Based on Armistice Capital's 13F filing for Q3 2016, filed 14 Nov 2016.